483 Atlas Pharmaceuticals Sep 2017

483 Atlas Pharmaceuticals Sep 2017

Stephanie Slater FDA$119.00 - Available Now

FDA investigators audited the Atlas Pharmaceuticals - Phoenix, AZ, United States facility and issued inspectional observations (via FDA 483) on 26 Sep 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Sep 2017
  • Location: Phoenix, United States
  • FEI: 3013030904
Add To Cart